Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma

被引：23
|
作者：
Nastoupil, Loretta J. [1 ,3 ]
Bartlett, Nancy L. [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Washington Univ, Siteman Canc Ctr, St Louis, MO USA
[3] Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Unit 429, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 04期
关键词：
RITUXIMAB PLUS CYCLOPHOSPHAMIDE; PREVIOUSLY UNTREATED PATIENTS; SOUTHWEST-ONCOLOGY-GROUP; NON-HODGKIN-LYMPHOMA; DOUBLE-HIT LYMPHOMA; SINGLE-ARM; OPEN-LABEL; ELDERLY-PATIENTS; PHASE-III; R-CHOP;
D O I：
10.1200/JCO.22.01848
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a heterogenous group of morphologically, genetically, and clinically distinct diseases. Several recent advances have affected the treatment landscape, which had been mostly stagnant for the past few decades. We will review the practice-changing studies in frontline (POLARIX), early relapse (ZUMA-7 and TRANSFORM), and multiple recurrent (ZUMA-1, JULIET, TRANSCEND, L-MIND, and LOTIS-2) stages and discuss how the treatment landscape may evolve with the emergence of bispecific antibodies.
引用
收藏
页码：903 / +
页数：12
相关论文
共 50 条
  • [1] Diffuse Large B-Cell Lymphoma
    Sehn, Laurie H.
    Salles, Gilles
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 842 - 858
  • [2] Treatment strategies for patients with diffuse large B-cell lymphoma
    Poletto, Stefano
    Novo, Mattia
    Paruzzo, Luca
    Frascione, Pio Manlio Mirko
    Vitolo, Umberto
    CANCER TREATMENT REVIEWS, 2022, 110
  • [3] Treatment resistance in diffuse large B-cell lymphoma
    He, Michael Y.
    Kridel, Robert
    LEUKEMIA, 2021, 35 (08) : 2151 - 2165
  • [4] Translating the Biology of Diffuse Large B-cell Lymphoma Into Treatment
    Danilov, Alexey, V
    Magagnoli, Massimo
    Matasar, Matthew J.
    ONCOLOGIST, 2022, 27 (01): : 57 - 66
  • [5] Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations
    Chan, Jason Yongsheng
    Somasundaram, Nagavalli
    Grigoropoulos, Nicholas
    Lim, Francesca
    Poon, Michelle Limei
    Jeyasekharan, Anand
    Yeoh, Kheng Wei
    Tan, Daryl
    Lenz, Georg
    Ong, Choon Kiat
    Lim, Soon Thye
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [6] Identifying aggressive subsets within diffuse large B-cell lymphoma: implications for treatment approach
    Voorhees, Timothy J.
    Epperla, Narendranath
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (05) : 523 - 533
  • [7] New treatment options in elderly patients with Diffuse Large B-cell Lymphoma
    Arcari, Annalisa
    Cavallo, Federica
    Puccini, Benedetta
    Vallisa, Daniele
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] New Insights into First-Line Therapy in Diffuse Large B-Cell Lymphoma: Are We Improving Outcomes?
    Abrisqueta, Pau
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [9] Frontline treatment of diffuse large B-cell lymphoma: Beyond R-CHOP
    Mondello, Patrizia
    Mian, Michael
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 333 - 344
  • [10] How to Treat Diffuse Large B-Cell Lymphoma Oncologic and Cardiovascular Considerations
    Thiruvengadam, Swetha Kambhampati
    Herrera, Alex F.
    Rhee, June-Wha
    JACC: CARDIOONCOLOGY, 2023, 5 (03): : 281 - 291
12345